Completed PHASE4 INTERVENTIONAL 2-arm NCT01729559

Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin

Venous Thromboembolic Prophylaxis After Major Trauma: A Randomized Controlled Trial of Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin

Sponsor: Scripps Health

Conditions Deep Vein Thrombosis Pulmonary Embolism Venous Thromboembolic Disease

Interventions 30mg enoxaparin Q12 hr 5000 Units unfractionated Heparin Q 8 hr

Updated 6 times since 2017 Last updated: Jun 7, 2016 Started: Nov 30, 2012 Primary completion: Sep 30, 2014 Completion: Oct 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01729559, this PHASE4 trial focuses on Deep Vein Thrombosis and Pulmonary Embolism and remains completed. Sponsored by Scripps Health, it has been updated 6 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Dec 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Dec 2021 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Nov 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Scripps Health

Data source: Scripps Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• San Diego, United States